UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002158
Receipt number R000002634
Scientific Title Clinical study of MP plus zoledronic acid therapy in newly diagnosed multiple myeloma excluding stem cell transplantation patients
Date of disclosure of the study information 2009/07/06
Last modified on 2009/07/02 15:43:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical study of MP plus zoledronic acid therapy in newly diagnosed multiple myeloma excluding stem cell transplantation patients

Acronym

MP plus zoledronic acid therapy in newly diagnosed multiple myeloma

Scientific Title

Clinical study of MP plus zoledronic acid therapy in newly diagnosed multiple myeloma excluding stem cell transplantation patients

Scientific Title:Acronym

MP plus zoledronic acid therapy in newly diagnosed multiple myeloma

Region

Japan


Condition

Condition

Multiple Myeloma

Classification by specialty

Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Analysis of MP plus zoledronic acid therapy for newly diagnosed nultiple myeloma excluding stem cell transplantation patients

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Analysis of skeletal-related events on 48 weeks after treatment.

Key secondary outcomes

Analysis of skeletal-related events on 104 weeks after treatment.
Response rate of MP plus zoledronic acid on 48 weeks after treatment.
Analysis of bone metabolism marker.
Analysis of bone density (L2-L4) using DXA method.
Frequency of therapy-related toxicity.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Newly diagnosed multiple myeloma using IMWG criteria excluding stem cell transplantaion patient.
Detection of M protein by serum or urine.
Monoclonarity of plasma cell in BM or plasmacytoma.
Organ disorder: renal failure (Cr>2mg/dl), anemia (Hb<10g/dl,or over 2g/dl decreased), bone lesion (lytic lesion or osteoporosis with compression fracture), others (hyperviscosity syndrome, amyloidosis, bacterial infection (over 2 times/ year)
(2)Definition of exclusion of stem cell transplantation.
Imposssible for high dose chemotherapy or disagreement of SCT.
(3) Osteolytic bone disease diagnosed by X-P, CT or MRI.
(4) Over 1 year survival patient
(5) No severe organ damage
AST (under 2 times of limit level)
ALT (under 2 times of limit level)
T-Bil (under 2 times of limit level)
Ccr 30 ml/min
(6) Informed consent by document

Key exclusion criteria

(1)Treatment history with bisphosphonate within 3 years.
(2) Double cancer (or more) or cancer past history.
(3)Uncontrollable any complication or infection.
(4) Class III or IV heart disease by NYHA classification.
(5) Under pregnancy, breast-feeding.
(6) Dental infection (within 4 weeks after dental treatment).
(7)Viral hepatitis (HBs antigen or HCV antibody positive)
(8) Patient applied other clinical study.
(9)Others (inappropriate case)

Target sample size

5


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name HIrokazu Murakami

Organization

Gunma University

Division name

Division of health

Zip code


Address

Showa-machi 3-39-15, Mebashi-shi, Gunma

TEL

027-220-8973

Email



Public contact

Name of contact person

1st name
Middle name
Last name Hiroshi Handa

Organization

Gunma University

Division name

Division of health

Zip code


Address

Showa-machi 3-39-15, Mebashi-shi, Gunma

TEL

027-220-8973

Homepage URL


Email

hhanda@health.gunma-u.ac.jp


Sponsor or person

Institute

Division of clinial oncology and hematology, Jikei University School of
Medicine


Institute

Department

Personal name



Funding Source

Organization

Gumma University, and Jikei University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 07 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2009 Year 07 Month 06 Day

Date of IRB


Anticipated trial start date

2009 Year 07 Month 01 Day

Last follow-up date

2012 Year 12 Month 01 Day

Date of closure to data entry

2012 Year 12 Month 01 Day

Date trial data considered complete

2012 Year 12 Month 01 Day

Date analysis concluded

2013 Year 06 Month 01 Day


Other

Other related information

Under investigation


Management information

Registered date

2009 Year 07 Month 02 Day

Last modified on

2009 Year 07 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002634


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name